Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $40.0 million.

  • Maxcyte's Change in Acquisitions & Divestments fell 697.67% to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.6 million, marking a year-over-year decrease of 2367.35%. This contributed to the annual value of $159.4 million for FY2024, which is 4918.57% down from last year.
  • As of Q3 2025, Maxcyte's Change in Acquisitions & Divestments stood at $40.0 million, which was down 697.67% from $31.0 million recorded in Q2 2025.
  • In the past 5 years, Maxcyte's Change in Acquisitions & Divestments ranged from a high of $200.8 million in Q1 2022 and a low of $6.0 million during Q3 2021
  • For the 5-year period, Maxcyte's Change in Acquisitions & Divestments averaged around $52.9 million, with its median value being $44.8 million (2024).
  • As far as peak fluctuations go, Maxcyte's Change in Acquisitions & Divestments skyrocketed by 115497.5% in 2022, and later crashed by 6129.21% in 2024.
  • Quarter analysis of 5 years shows Maxcyte's Change in Acquisitions & Divestments stood at $55.5 million in 2021, then decreased by 5.41% to $52.5 million in 2022, then increased by 26.19% to $66.2 million in 2023, then tumbled by 53.21% to $31.0 million in 2024, then rose by 29.03% to $40.0 million in 2025.
  • Its last three reported values are $40.0 million in Q3 2025, $31.0 million for Q2 2025, and $46.6 million during Q1 2025.